Aureus Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
11,787
+99
+0.8% +$11.4K 0.09% 96
2025
Q4
$1.23M Buy
11,688
+1,414
+14% +$133K 0.08% 88
2025
Q3
$862K Sell
10,274
-1,707
-14% -$141K 0.06% 97
2025
Q2
$948K Sell
11,981
-46,288
-79% -$3.68M 0.06% 95
2025
Q1
$5.23M Buy
58,269
+14,704
+34% +$1.37M 0.37% 50
2024
Q4
$4.33M Sell
43,565
-7,432
-15% -$766K 0.28% 54
2024
Q3
$5.79M Buy
50,997
+9,130
+22% +$1.08M 0.38% 49
2024
Q2
$5.18M Buy
41,867
+8,038
+24% +$1.04M 0.36% 47
2024
Q1
$4.46M Buy
33,829
+22,189
+191% +$2.73M 0.3% 55
2023
Q4
$1.27M Buy
11,640
+256
+2% +$26.6K 0.09% 79
2023
Q3
$1.17M Buy
11,384
+1,062
+10% +$114K 0.09% 85
2023
Q2
$1.19M Buy
10,322
+106
+1% +$12K 0.09% 84
2023
Q1
$1.09M Sell
10,216
-10
-0.1% -$1.08K 0.09% 84
2022
Q4
$1.13M Sell
10,226
-186
-2% -$19K 0.1% 90
2022
Q3
$897K Sell
10,412
-1,881
-15% -$168K 0.08% 91
2022
Q2
$1.12M Buy
12,293
+430
+4% +$38.1K 0.09% 88
2022
Q1
$973K Buy
11,863
+310
+3% +$24.4K 0.06% 107
2021
Q4
$885K Buy
11,553
+771
+7% +$61.4K 0.05% 103
2021
Q3
$810K Buy
10,782
+270
+3% +$20.5K 0.05% 105
2021
Q2
$818K Sell
10,512
-288
-3% -$21.4K 0.05% 110
2021
Q1
$794K Sell
10,800
-6,032
-36% -$445K 0.06% 91
2020
Q4
$1.31M Buy
16,832
+639
+4% +$48.9K 0.11% 77
2020
Q3
$1.28M Sell
16,193
-2,326
-13% -$182K 0.12% 70
2020
Q2
$1.37M Sell
18,519
-1,544
-8% -$116K 0.15% 63
2020
Q1
$1.47M Sell
20,063
-1,093
-5% -$85.9K 0.2% 54
2019
Q4
$1.84M Buy
21,156
+1,536
+8% +$126K 0.21% 59
2019
Q3
$1.58M Hold
19,620
0.2% 57
2019
Q2
$1.57M Sell
19,620
-2,588
-12% -$198K 0.19% 58
2019
Q1
$1.76M Sell
22,208
-84
-0.4% -$6.28K 0.23% 54
2018
Q4
$1.63M Buy
22,292
+662
+3% +$46.7K 0.26% 53
2018
Q3
$1.46M Hold
21,630
0.19% 60
2018
Q2
$1.25M Buy
21,630
+5,657
+35% +$319K 0.17% 67
2018
Q1
$830K Buy
15,973
+1,036
+7% +$56K 0.12% 81
2017
Q4
$802K Sell
14,937
-1,552
-9% -$86K 0.12% 83
2017
Q3
$1.01M Buy
16,489
+7,388
+81% +$448K 0.16% 67
2017
Q2
$557K Sell
9,101
-230
-2% -$14K 0.09% 90
2017
Q1
$574K Buy
9,331
+4,244
+83% +$257K 0.1% 92
2016
Q4
$286K Sell
5,087
-1,323
-21% -$77.4K 0.06% 116
2016
Q3
$382K Buy
6,410
+1,458
+29% +$85.3K 0.08% 97
2016
Q2
$272K Buy
+4,952
New +$264K 0.06% 101
2016
Q1
Sell
-228,698
Closed -$11.5M 132
2015
Q4
$11.5M Sell
228,698
-3,083
-1% -$155K 2.59% 17
2015
Q3
$10.9M Sell
231,781
-2,808
-1% -$149K 2.72% 13
2015
Q2
$12.7M Buy
234,589
+16,673
+8% +$935K 2.68% 6
2015
Q1
$12M Buy
217,916
+4,985
+2% +$282K 2.75% 3
2014
Q4
$11.5M Sell
212,931
-3,614
-2% -$201K 2.81% 4
2014
Q3
$12.2M Buy
216,545
+2,924
+1% +$164K 3.07% 2
2014
Q2
$11.8M Buy
213,621
+13,186
+7% +$719K 2.95% 2
2014
Q1
$10.9M Buy
200,435
+7,879
+4% +$408K 2.79% 2
2013
Q4
$9.2M Buy
192,556
+28,914
+18% +$1.32M 2.49% 5
2013
Q3
$7.43M Buy
163,642
+5,505
+3% +$251K 2.54% 4
2013
Q2
$7.01M Buy
+158,137
New +$7.06M 2.51% 5

Other funds holding MRK

Aureus Asset Management's MRK Position: Q1 2026 in Review

Aureus Asset Management increased its Merck (MRK) stake by 0.85% in Q1 2026, buying an estimated $11.4K and bringing the position to 11,787 shares worth $1.42M. The position accounts for 0.09% of the portfolio, ranked #96.

Aureus Asset Management first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.7M in Q2 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Aureus Asset Management held 11,787 shares of Merck worth $1.42M as of Q1 2026.
  • Aureus Asset Management bought 99 Merck shares in Q1 2026, an estimated $11.4K.
  • Merck made up 0.09% of Aureus Asset Management's portfolio in Q1 2026, its #96 holding.
  • Aureus Asset Management first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Aureus Asset Management's Merck position peaked at $12.7M in Q2 2015.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.